Introducing multiple vaccines in low- and lower-middle-income countries: Issues, opportunities and challenges

Health Policy and Planning

Volumn 27, Issue SUPPL.2, 2012, Pages

  Gordon, W Scott ^a   Jones, Andrew ^b   Wecker, John ^a  

^a PATH   (United States)

^b Adeni Consulting   (United States)

Author keywords

GAVI; immunization; immunization policy; planning; vaccine introduction; Vaccines; WHO

Indexed keywords

VACCINE;

ARTICLE; DEVELOPING COUNTRY; ECONOMICS; EDUCATION; HUMAN; MANAGEMENT; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE;

DECISION MAKING, ORGANIZATIONAL; DEVELOPING COUNTRIES; EDUCATION; HUMANS; IMMUNIZATION PROGRAMS; POLICY MAKING; VACCINES;

EID: 84860199500     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czs040     Document Type: Article

References (29)

1. Al Awaidy SA, Bawikar S, Al Busaidy S et al. 2009. Considerations for introduction of a rotavirus vaccine in Oman: rotavirus disease and economic burden. Journal of Infectious Diseases 200(Suppl. 1):S248-53.
2. Andrus JK, Fitzsimmons J. 2005. Introduction of new and underutilized vaccines: sustaining access, disease control, and infrastructure development. PLoS Medicine 2: e286.
3. Bill & Melinda Gates Foundation. 2010. Global Health Leaders Launch Decade of Vaccines Collaboration. Press release. 2 December 2010. Seattle, WA: Bill & Melinda Gates Foundation.
4. Bryson M, Duclos P, Jolly A, Bryson J. 2010a. A systematic review of national immunization policy making processes. Vaccine 28(Suppl. 1):A6-12.
5. Bryson M, Duclos P, Jolly A, Cakmak N. 2010b. A global look at national Immunization Technical Advisory Groups. Vaccine 28(Suppl. 1):A13-17.
6. Burns JE, Mitrovich RC, Jauregui B, Matus CR, Andrus JK. 2009. Descriptive analysis of immunization policy decision making in the Americas. Revista Panamerica de Salud Publica 26: 398-404.
7. Cervantes-Apolinar MY, Cassart JP, Bouckenooghe A. 2006. Introduction of human rotavirus vaccine in Latin America. Archives of Medical Research 37: 568-9.
8. DeRoeck D, Clemens JD, Nyamete A, Mahoney RT. 2005. Policy makers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 23: 2762-74.
9. EPI Newsletter. 1999. Introduction of Hib vaccine in the Americas: lessons learned. EPI Newsletter 21: 4-5.
10. FitzSimons D, Van DP, Emiroglu N et al. 2002. Strengthening immunization systems and introduction of hepatitis B vaccine in central and Eastern Europe and the newly independent states. Vaccine 20: 1475-9.
11. Garcia S, Levine OS, Cherian T, Gabastou JM, Andrus J. 2006. Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction. Revista Panamerica de Salud Publica 19: 340-8.
12. GAVI Alliance. 2005. Lessons Learned from GAVI Phase 1 and design of Phase 2: Findings of the Country Consultation Process. Report to GAVI Secretariat. London: HLSP. Online at: www.gavialliance.org/resources/Lessons- learned-Phase-1-July05.pdf, accessed 25 February 2011.
13. GAVI Alliance. 2011. Guidelines on Country Proposals for Support for New and Underutilized Vaccines. Geneva: GAVI. Online at: www.gavialliance.org/ resources/GAVI-Guidelines-2011-Round.pdf, accessed 25 February 2011.
14. GAVI Alliance. 2012. FAQs on Graduating Countries. Geneva: GAVI. Online at: http://www.gavialliance.org/support/apply/faqs-aboutgraduating, accessed 9 March 2012.
15. Griffiths UK, Clark AD, Mulholland KM. 2009. Introduction of rotavirus vaccine. British Medical Journal 339: b3482.
16. Lee BY, Assi T-M, Rookkapan K et al. 2011a. Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand. PLoS One 6: e24673.
17. Lee BY, Assi T-M, Rajgopal J et al. 2011b. Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger. American Journal of Public Health 102: 269-76.
18. Kamara L, Milstien JB, Patyna M et al. 2008. Strategies for financial sustainability of immunization programs: a review of the strategies from 50 national immunization program financial sustainability plans. Vaccine 26: 6717-26.
19. Miller MA, McCann L. 2000. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniaeconjugate and rotavirus vaccines in national immunization schedules. Health Economics 9: 19-35.
20. Puliyel JM. 2004. Policy analysis of the use of hepatitis B, Hemophilius influenzae type B, Steptococcus pneuomniae-conjugate and rotavirus vaccines in the national immunization schedules. Health Economics 13: 1147-8.
21. Rossi IA, Zuber PL, Dumolard L, Walker DG, Watt J. 2007. Introduction of Hib vaccine into national immunization programmes: a descriptive analysis of global trends. Vaccine 25: 7075-80.
22. Shearer JC, Stack ML, Richmond MR et al. 2010. Accelerating policy decisions to adopt Haemophilus influenzae type b vaccine: a global, multivariable analysis. PLoS Medicine 7: e1000249.
23. United Republic of Tanzania. 2008. Expanded Programme on Immunization 2006-2010 Comprehensive Multi Year Plan. 3rd version. United Republic of Tanzania, Ministry of Health and Social Welfare - Tanzania Mainland.
24. Wenger JD, DiFabio J, Landaverde JM, Levine OS, Gaafar T. 1999. Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countries. Vaccine 18: 736-42.
25. World Health Organization (WHO). 2005. Global Immunization Vision and Strategy 2006-2015. Geneva: WHO and UNICEF. Online at: http://www.who.int/ vaccines-documents/DocsPDF05/GIVS-Final-EN.pdf, accessed 21 March 2012.
26. World Health Organization (WHO). 2008. Immunization financing database. Geneva. Online at: http://www.who.int/immunization-financing/data, accessed 25 February 2011.
27. World Health Organization (WHO). 2006. WHO-UNICEF Guidelines for Developing a Comprehensive Multi-Year Plan (cMYP). Geneva: WHO. Document WHO/IVB/05.20.
28. World Health Organization (WHO). 2010. Meeting of the Strategic Advisory Group of Experts on immunization, April 2010 - conclusions and recommendations. Weekly Epidemiological Record 85: 197-2012.
29. Zuber PL, El-Ziq I, Kaddar M et al. 2011. Sustaining GAVI-supported vaccine introductions in resource poor-countries. Vaccine 29: 3149-54.